Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz,, Graz, Austria.
Liver Int. 2012 May;32(5):845-51. doi: 10.1111/j.1478-3231.2011.02735.x. Epub 2012 Jan 4.
Previous studies suggest that chronic liver disease may be related to vitamin D deficiency. It is, however, not known whether 25(OH)D levels are associated with incident hepatic decompensation and mortality in chronic liver failure.
We aimed to evaluate whether 25(OH)D serum levels are associated with Child-Pugh (CP) score, model for end-stage liver disease (MELD) score, occurrence of hepatic decompensation, and survival in patients with cirrhosis.
We enrolled 75 consecutive cirrhotic patients admitted to our outpatient liver clinic (32% females; age: 58 ± 11 years; aetiology alcohol in 61%). At baseline, 25(OH)D was determined and the degree of liver dysfunction was estimated by CP and MELD score. Thereafter patients were followed-up with respect to hepatic decompensation and mortality.
25(OH)D levels averaged 16.0 ± 9.2 ng/ml and were inversely correlated with MELD score (r = -0.34, P = 0.003) and CP score (r = -0.21, P = 0.080). Thirty-seven patients developed hepatic decompensation and 24 patients died during a median follow-up of 3.6 years. Age- and gender-adjusted relative risk (with 95% confidence interval) was 6.37 (1.75-23.2; P = 0.005) for hepatic decompensation and 4.31 (1.38-13.5; P = 0.012) for mortality within the first vs the third 25(OH)D tertile but these associations were largely attenuated towards non-significant trends after additional adjustments for CP or MELD score.
Our findings show a significant association of 25(OH)D with the degree of liver dysfunction and suggest that low 25(OH)D levels may predict hepatic decompensation and mortality in patients with chronic liver failure.
先前的研究表明,慢性肝病可能与维生素 D 缺乏有关。然而,慢性肝衰竭患者 25(OH)D 水平是否与肝性失代偿和死亡率有关尚不清楚。
我们旨在评估 25(OH)D 血清水平是否与慢性肝衰竭患者的 Child-Pugh (CP)评分、终末期肝病模型 (MELD)评分、肝性失代偿的发生和生存率相关。
我们纳入了 75 例连续就诊于我们门诊肝脏诊所的肝硬化患者(32%为女性;年龄:58 ± 11 岁;病因:酒精 61%)。基线时,测定 25(OH)D 水平,并通过 CP 和 MELD 评分评估肝功能不全程度。随后,对患者进行肝性失代偿和死亡率的随访。
25(OH)D 水平平均为 16.0 ± 9.2ng/ml,与 MELD 评分(r = -0.34,P = 0.003)和 CP 评分(r = -0.21,P = 0.080)呈负相关。37 例患者发生肝性失代偿,24 例患者在中位随访 3.6 年后死亡。年龄和性别调整后的相对风险(95%置信区间)为 6.37(1.75-23.2;P = 0.005)肝性失代偿和 4.31(1.38-13.5;P = 0.012)死亡率在第一个与第三个 25(OH)D 三分位组之间,但这些关联在进一步调整 CP 或 MELD 评分后,大多呈非显著趋势。
我们的发现表明 25(OH)D 与肝功能障碍程度显著相关,并表明慢性肝衰竭患者 25(OH)D 水平低可能预测肝性失代偿和死亡率。